Eylea 2 mg/0.05 mL pre-filled syringe Images
Generic Name: aflibercept
This medication has been identified as Eylea 2 mg/0.05 mL pre-filled syringe. It is supplied by Regeneron Pharmaceuticals, Inc.
Eylea is used in the treatment of Macular Edema Following Retinal Vein Occlusion ; Macular Degeneration; Macular Edema; Diabetic Macular Edema; Diabetic Retinopathy and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Eylea 2 mg/0.05 mL pre-filled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Eylea
- Generic Name
- aflibercept
- Strength
- 2 mg/0.05 mL pre-filled syringe
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Regeneron Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 61755-0005
More about Eylea (aflibercept ophthalmic)
- Compare alternatives
- Pricing & coupons
- Reviews (63)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
